Edition:
United Kingdom

Spring Bank Pharmaceuticals Inc (SBPH.OQ)

SBPH.OQ on NASDAQ Stock Exchange Capital Market

12.13USD
15 Dec 2017
Change (% chg)

$0.04 (+0.33%)
Prev Close
$12.09
Open
$12.16
Day's High
$12.45
Day's Low
$11.89
Volume
15,604
Avg. Vol
9,359
52-wk High
$18.93
52-wk Low
$6.40

Select another date:

Wed, Nov 15 2017

BRIEF-Spring Bank Pharmaceuticals announces positive top-line results from the second cohort of part A of the phase 2 achieve trial

* Spring Bank Pharmaceuticals announces positive top-line results from the second cohort of part A of the phase 2 achieve trial

BRIEF-Spring Bank Pharmaceuticals may offer and sell shares of up to $50 mln common stock

* Spring Bank Pharmaceuticals Inc files to say may offer and sell shares of up to $50 million of common stock - SEC filing Source text: (http://bit.ly/2wpauAR) Further company coverage:

BRIEF-BVF Partners reports 5.1 pct passive stake in Spring Bank Pharmaceuticals as of Aug. 3

* BVF Partners L.P reports 5.1 percent passive stake in spring bank pharmaceuticals inc as of august 3, 2017 - SEC filing‍​ Source text (http://bit.ly/2vWRyKp) Further company coverage:

BRIEF-Spring Bank Pharmaceuticals posts Q2 loss per share $0.93

* Spring Bank Pharmaceuticals provides corporate update and reports second quarter 2017 financial and operational results

BRIEF-Spring Bank Pharmaceuticals announces clinical trial collaboration with Gilead Sciences for clinical study examining SB 9200​

* Spring Bank Pharmaceuticals Inc - ‍announced a second clinical trial collaboration with Gilead Sciences, Inc. for a clinical study examining SB 9200​

BRIEF-Spring Bank Pharma prices $37.5 mln public offering of common stock

* Spring bank pharmaceuticals prices $37.5 million public offering of common stock

BRIEF-Spring Bank Pharma announces proposed public offering of common stock

* Spring Bank Pharmaceuticals announces proposed public offering of common stock

Select another date: